Inter‐laboratory multiplex bead‐based surface protein profiling of MSC‐derived EV preparations identifies MSC‐EV surface marker signatures
Journal of Extracellular Vesicles · 2024-06 · 13 (6)
DOI: 10.1002/jev2.12463 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 13.06.2024. Verfasst von Vivian V T Nguyen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, UMC Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Vesicles, Flow Cytometry, Protein Array Analysis. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: RECONNECT YTP 'CHIPS' grant, International Society for Advancement of Cytometry, IAF-PP HHP domain.
Abstract (Originalsprache)
Mesenchymal stromal cells (MSCs) are promising regenerative therapeutics that primarily exert their effects through secreted extracellular vesicles (EVs). These EVs – being small and non‐living – are easier to handle and possess advantages over cellular products. Consequently, the therapeutic potential of MSC‐EVs is increasingly investigated. However, due to variations in MSC‐EV manufacturing strategies, MSC‐EV products should be considered as highly diverse. Moreover, the diverse array of EV characterisation technologies used for MSC‐EV characterisation further complicates reliable interlaboratory comparisons of published data. Consequently, this study aimed to establish a common method that can easily be used by various MSC‐EV researchers to characterise MSC‐EV preparations to facilitate interlaboratory comparisons. To this end, we conducted a comprehensive inter‐laboratory assessment using a novel multiplex bead‐based EV flow cytometry assay panel. This assessment involved 11 different MSC‐EV products from five laboratories with varying MSC sources, culture conditions, and EV preparation methods. Through this assay panel covering a range of mostly MSC‐related markers, we identified a set of cell surface markers consistently positive (CD44, CD73 and CD105) or negative (CD11b, CD45 and CD197) on EVs of all explored MSC‐EV preparations. Hierarchical clustering analysis revealed distinct surface marker profiles associated with specific preparation processes and laboratory conditions. We propose CD73, CD105 and CD44 as robust positive markers for minimally identifying MSC‐derived EVs and CD11b, CD14, CD19, CD45 and CD79 as reliable negative markers. Additionally, we highlight the influence of culture medium components, particularly human platelet lysate, on EV surface marker profiles, underscoring the influence of culture conditions on resulting EV products. This standardisable approach for MSC‐EV surface marker profiling offers a tool for routine characterisation of manufactured EV products in pre‐clinical and clinical research, enhances the quality control of MSC‐EV preparations, and hopefully paves the way for higher consistency and reproducibility in the emerging therapeutic MSC‐EV field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Hypertension, UMC Utrecht, Utrecht, The Netherlands.
- Translational Nanobiology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
- The Measuring Stick, Ltd, Peterborough, UK.
- Advanced Technology Group, Becton Dickinson, San Jose, California, USA.
- Institute for Transfusion Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
- Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
ORCID-Profile: Joshua A Welsh, Tobias Tertel, Pieter Vader, Sai Kiang Lim, Bas W M van Balkom, André Görgens
Förderung
- RECONNECT YTP 'CHIPS' grant
- International Society for Advancement of Cytometry
- IAF-PP HHP domain
- Health∼Holland TKI-LSH
- Netherlands Organization for Scientific Research
- Karolinska Institutet Network Medicine Global Alliance grant
- Fourth Framework Programme H2020 research and innovation programme under Mari
- Dutch Society for the Replacement of Animal Testing
Zitieren
APA
Nguyen, V. V. T., Welsh, J. A., Tertel, T., Choo, A., van de Wakker, S. I., Defourny, K. A. Y., Giebel, B., Vader, P., Padmanabhan, J., Lim, S. K., Nolte-'t Hoen, E. N. M., Verhaar, M. C., Bostancioglu, R. B., Zickler, A. M., Hong, J. M., Jones, J. C., El Andaloussi, S., van Balkom, B. W. M., & Görgens, A. (2024). Inter‐laboratory multiplex bead‐based surface protein profiling of MSC‐derived EV preparations identifies MSC‐EV surface marker signatures. Journal of Extracellular Vesicles, 13(6). https://doi.org/10.1002/jev2.12463
Vancouver
Nguyen VVT, Welsh JA, Tertel T, Choo A, van de Wakker SI, Defourny KAY, et al. Inter‐laboratory multiplex bead‐based surface protein profiling of MSC‐derived EV preparations identifies MSC‐EV surface marker signatures. Journal of Extracellular Vesicles. 2024;13(6). doi:10.1002/jev2.12463
BibTeX
@article{Nguyen2024,
author = {Nguyen, Vivian V T and Welsh, Joshua A and Tertel, Tobias and Choo, Andre and van de Wakker, Simonides I and Defourny, Kyra A Y and Giebel, Bernd and Vader, Pieter and Padmanabhan, Jayanthi and Lim, Sai Kiang and Nolte-'t Hoen, Esther N M and Verhaar, Marianne C and Bostancioglu, R Beklem and Zickler, Antje M and Hong, Jia Mei and Jones, Jennifer C and El Andaloussi, Samir and van Balkom, Bas W M and Görgens, André},
title = {Inter‐laboratory multiplex bead‐based surface protein profiling of MSC‐derived EV preparations identifies MSC‐EV surface marker signatures},
journal = {Journal of Extracellular Vesicles},
year = {2024},
volume = {13},
number = {6},
doi = {10.1002/jev2.12463}
}
EUVIMED